Rophibio Inc.

About Rophibio Inc.

Rophibio Inc. - Biosimilar & Biopharmaceutical Company Platform Technologies - Cell Line Development Platform - Complete Biosimilar Development Infrastructure Location - South Korea Founded - 2015 Preparing to undergo Global Phase 3 CT for Rophibio's Aflibercept biosimilar in 4Q-2023. Looking for potential L/O Opportunities or Long-Term...

  • KR
  • 2023
    On CPHI since
  • 1 - 24
    Employees
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Contact info
  • 194-25 Osongsaengmyeong-1ro (SB Plaza 406), Osong-eup, 28160, Cheongju-si, Chungbuk, Korea, Republic Of